Impact of Berotralstat on Healthcare Resource Utilization in Patients with Hereditary Angioedema with Normal C1-Inhibitor

Orladeyo (berotralstat) - BioCryst Pharmaceuticals

https://events.rdmobile.com/Lists/Details/3220808

Bruce Zuraw MD 1; Tracy Yee 2; Francois Laliberte 3; Colleen Spencer 3; Sandra Nestler-Parr 2; Patrick Gillard 4; Sandra Christiansen MD 5

Feb 10, 2026